Don't Buy Into the Hype About Vyleesi for Low Sexual Desire in Women

September 2019

Vyleesi (vye-LEE-see, bremelanotide) will join Addyi (flibanserin) as a med for hypoactive sexual desire in premenopausal women.

Both have been called "female Viagra." But they're NOT vasodilators...they seem to work by affecting dopamine in the brain.

Vyleesi is used PRN...but it's a subcutaneous injection.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines Rethink Prevnar 13 for Healthy Seniors
Hypertension Consider Nuances When Managing Hypertension in Older Adults
Pneumonia Don't Automatically Add Empiric Anaerobic Coverage for Aspiration Pneumonia
ADHD Solve Common Dilemmas With ADHD Stimulants
Scabies Consider Patient Preferences When Treating Scabies
Diabetes Help Patients With Diabetes Decipher Continuous Glucose Monitor Metrics
Sleep Disorders Lean Away From Sunosi for Excessive Daytime Sleepiness
Anticholinergics Look for Opportunities to Limit Anticholinergic Meds in Older Adults
Kidney Disease Emphasize Adherence With Phosphate Binders in Chronic Kidney Disease
Sexual Dysfunction Don't Buy Into the Hype About Vyleesi for Low Sexual Desire in Women
Surgery Assess Perioperative Infection Risk for Immunosuppressants and Biologics